Pulmonx Price to Sales Ratio 2019-2024 | LUNG
Historical PS ratio values for Pulmonx (LUNG) over the last 10 years. The current P/S ratio for Pulmonx as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pulmonx P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-02 | 3.77 | 1.75 | |
| 2024-12-31 | 6.79 | $2.15 | 3.16 |
| 2024-09-30 | 8.29 | $2.05 | 4.05 |
| 2024-06-30 | 6.34 | $1.99 | 3.18 |
| 2024-03-31 | 9.27 | $1.91 | 4.84 |
| 2023-12-31 | 12.75 | $1.81 | 7.03 |
| 2023-09-30 | 10.33 | $1.72 | 6.00 |
| 2023-06-30 | 13.11 | $1.62 | 8.09 |
| 2023-03-31 | 11.18 | $1.54 | 7.25 |
| 2022-12-31 | 8.43 | $1.45 | 5.82 |
| 2022-09-30 | 16.66 | $1.41 | 11.79 |
| 2022-06-30 | 14.72 | $1.41 | 10.42 |
| 2022-03-31 | 24.81 | $1.37 | 18.05 |
| 2021-12-31 | 32.07 | $1.34 | 23.88 |
| 2021-09-30 | 35.98 | $1.93 | 18.65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.152B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||